Direct modulation of amino acid receptors by neuroactive steroids: Physiological and pharmacological implications

Neurosteroid Effects in the Central Nervous System: The Role of the GABA-A Receptor

Volumn , Issue , 2003, Pages 339-358

  Gibbs, Terrell T ^a   Farb, David H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649348674     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (34)

1. Wu, F.-S., Gibbs, T.T., and Farb, D.H., Inverse modulation of γ-aminobutyric acidand glycine-induced currents by progesterone, Mol. Pharmacol., 37, 597-602, 1990.
2. Harrison, N.L., Majewska, M.D., Harrington, J.W., and Barker, J.L., Structure-activity relationships for steroid interaction with the γ-aminobutyric acidA receptor complex, J. Pharmacol. Exp. Ther., 241, 346-353, 1987.
3. Rupprecht, R., The neuropsychopharmacological potential of neuroactive steroids, J. Psychiatr. Res., 31, 297-314, 1997.
4. Harrison, N.L. and Simmonds, M.A., Modulation of the GABA receptor complex by a steroid anaesthetic, Brain Res., 323, 287-292, 1984.
5. Cottrell, G.A., Lambert, J.J., and Peters, J.A., Modulation of GABAA receptor activity by alphaxalone, Br. J. Pharmacol., 90, 491-500, 1987.
6. Majewska, M.D. and Schwartz, R.D., Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? Brain Res., 404, 355-360, 1987.
7. Majewska, M.D., Demirgören, S., Spivak, C.E., and London, E.D., The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor, Brain Res., 526, 143-146, 1990.
8. Park-Chung, M., Malayev, A., Purdy, R.H., Gibbs, T.T., and Farb, D.H., Sulfated and unsulfated steroids modulate γ-aminobutyric acidA receptor function through distinct sites, Brain Res., 830, 72-87, 1999.
9. Chan, C.Y. and Farb, D.H., Modulation of neurotransmitter action: control of the γ- aminobutyric acid response through the benzodiazepine receptor, J. Neurosci., 5, 2365-2373, 1985.
10. Gyenes, M., Farrant, M., and Farb, D.H., “Run-down” of γ-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation, Mol. Pharmacol., 34, 719-723, 1988.
11. Gyenes, M., Wang, Q., Gibbs, T.T., and Farb, D.H., Phosphorylation factors control neurotransmitter and neuromodulator action at the γ-aminobutyric acid type A receptor, Mol. Pharmacol., 46, 542-549, 1994.
12. Roca, D.J., Schiller, G.D., Rozenberg, I., Gibbs, T.T., and Farb, D.H., γ-Aminobutyric acid receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines, Mol. Pharmacol., 37, 710-719, 1990.
13. Roca, D.J., Rozenberg, I., Farrant, M., and Farb, D.H., Chronic agonist exposure induces down regulation and allosteric uncoupling of the γ-aminobutyric acid/benzodiazepine receptor complex, Mol. Pharmacol., 37, 37-43, 1990.
14. Friedman, L.K., Gibbs, T.T., and Farb, D.H., γ-Aminobutyric acidA receptor regulation: heterologous uncoupling of modulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture, Brain Res., 707, 100-109, 1996.
15. Friedman, L., Gibbs, T.T., and Farb, D.H., γ-Aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites, Mol. Pharmacol., 44, 191-197, 1993.
16. Wo, Z. and Oswald, R., Unraveling the modular design of glutamate-gated ion channels, Trends Neurosci., 18, 161-168, 1995.
17. Choi, D.W., Excitotoxic cell death, J. Neurobiol., 23, 1261-1276, 1992.
18. Coyle, J.T. and Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689-695, 1993.
19. Wu, F.-S., Gibbs, T.T., and Farb, D.H., Pregnenolone sulfate: a positive allosteric modulator at the NMDA receptor, Mol. Pharmacol., 40, 333-336, 1991.
20. Park-Chung, M., Wu, F.-S., Purdy, R.H., Malayev, A.A., Gibbs, T.T., and Farb, D.H., Distinct sites for inverse modulation of NMDA receptors by sulfated steroids, Mol. Pharmacol., 52, 1113-1123, 1997.
21. Malayev, A.A., Gibbs, T.T., and Farb, D.H., Inhibition of the NMDA response by pregnenolone sulfate reveals subtype selective modulation of NMDA receptors by sulfated steroids, Br. J. Pharmacol., 135, 901-909, 2002.
22. Yaghoubi, N., Malayev, A., Russek, S.J., Gibbs, T.T., and Farb, D.H., Neurosteroid modulation of recombinant ionotropic glutamate receptors, Brain Res., 803, 153-160, 1998.
23. Irwin, R.P., Maragakis, N.J., Rogawski, M.A., Purdy, R.H., Farb, D.H., and Paul, S.M., Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons, Neurosci. Lett., 141, 30-34, 1992.
24. Park-Chung, M., Wu, F.-S., and Farb, D.H., 3α-Hydroxy-5β -pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons, Mol. Pharmacol., 46, 146-150, 1994.
25. Yaghoubi, N., Gibbs, T.T., and Farb, D.H., Evaluation of neurosteroid modulation of kainate receptors using an automated system for oocyte electrophysiology, Soc. Neurosci. Abstr., 20, 1109, 1995.
26. Irwin, R.P., Lin, S.-Z., Rogawski, M.A., Purdy, R.H., and Paul, S.M., Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure activity studies, J. Pharmacol. Exp. Ther., 271, 677-682, 1994.
27. Weaver, C.E., Jr., Land, M.B., Purdy, R.H., Richards, K.G., Gibbs, T.T., and Farb, D.H., Geometry and charge determine pharmacological effects of steroids on Nmethyl-D-aspartate receptor induced Ca2+ accumulation and cell death, J. Pharmacol. Exp. Ther., 293, 747-754, 2000.
28. Weaver, C.E., Jr., Park-Chung, M., Gibbs, T.T., and Farb, D.H., 17β -Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors, Brain Res., 761, 338-341, 1997.
29. Weaver, C.E., Jr., Marek, P., Park-Chung, M., Tam, S.W., and Farb, D.H., Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor, Proc. Natl. Acad. Sci. U.S.A., 94, 10450-10454, 1997.
30. Sadri-Vakili, G., Johnson, D.W., Janis, G.C., Gibbs, T.T., Pierce, R.C., and Farb, D.H., Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3α-hydroxy-5β -pregnan-20-one hemisuccinate, J. Neurochem., 86, 92-101, 2003.
31. Sadri-Vakili, G., Janis, G.C., Gibbs, T.T., Pierce, R.C., and Farb, D.H., Pregnenolone sulfate increases dopamine release in the rat striatum, Soc. Neurosci. Abstr., 28, 640.8, 2002.
32. Gibbs, T.T. and Farb, D.H., Dueling enigmas: neurosteroids and sigma receptors in the limelight, Sci. STKE, 2000, PE1, 2000.
33. Su, T.P., London, E.D., and Jaffe, J.H., Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems, Science, 240, 219-221, 1988.
34. Monnet, F.P., Mahe, V., Robel, P., and Baulieu, E.E., Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus, Proc. Natl. Acad. Sci. U.S.A., 92, 3774-3778, 1995.